Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America - Wikidata - wikimedia - TriplyDB

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

http://www.wikidata.org/entity/Q28272494

about

Diagnosis and management of invasive candidiasis in the ICU: an updated approach to an old enemy Recent developments in the management of invasive fungal infections in patients with oncohematological diseases Epidemiology of Blood Stream Infection due to Candida Species in a Tertiary Care Hospital in Japan over 12 Years: Importance of Peripheral Line-Associated Candidemia The Extracellular Matrix of Candida albicans Biofilms Impairs Formation of Neutrophil Extracellular Traps Preclinical Evaluation of the Stability, Safety, and Efficacy of CD101, a Novel Echinocandin Intensive care medicine research agenda on invasive fungal infection in critically ill patients.Congenital Cutaneous Candidiasis: Prompt Systemic Treatment Is Associated With Improved Outcomes in Neonates.Voriconazole treatment of Candida tropicalis meningitis: persistence of (1,3)-β-D-glucan in the cerebrospinal fluid is a marker of clinical and microbiological failure: A case report.Specific Human and Candida Cellular Interactions Lead to Controlled or Persistent Infection Outcomes during Granuloma-Like Formation.A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes Management of intra-abdominal infections: recommendations by the WSES 2016 consensus conference Clinical and microbiological characteristics, and impact of therapeutic strategies on the outcomes of children with candidemia.Molecular Epidemiology and Antifungal Susceptibility of Candida glabrata in China (August 2009 to July 2014): A Multi-Center Study.Invasive Candida Infections in Liver Transplant Recipients: Clinical Features and Risk Factors for Mortality.Pharmacoeconomic analysis of antifungal therapy for primary treatment of invasive candidiasis caused by Candida albicans and non-albicans Candida species.The management of intra-abdominal infections from a global perspective: 2017 WSES guidelines for management of intra-abdominal infections.Identification of Ebsulfur Analogues with Broad-Spectrum Antifungal Activity Empiric treatment against invasive fungal diseases in febrile neutropenic patients: a systematic review and network meta-analysis Measuring (1,3)-β-D-glucan in tracheal aspirate, bronchoalveolar lavage fluid, and serum for detection of suspected Candida pneumonia in immunocompromised and critically ill patients: a prospective observational study.Convergence of Minds: For Better Patient Outcome in Intensive Care Unit Infections Anidulafungin for the treatment of candidaemia caused by Candida parapsilosis: Analysis of pooled data from six prospective clinical studies.Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections.Candida duobushaemulonii: an emerging rare pathogenic yeast isolated from recurrent vulvovaginal candidiasis in Brazil.CNS infections in patients with hematological disorders (including allogeneic stem-cell transplantation)-Guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO).Activity of a long-acting echinocandin, CD101, determined using CLSI and EUCAST reference methods, against Candida and Aspergillus spp., including echinocandin- and azole-resistant isolates.A complex game of hide and seek: the search for new antifungals CD101: a novel long-acting echinocandin.Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species.Recommendations for intra-abdominal infections consensus report.Safety and Pharmacokinetics of CD101 IV, a Novel Echinocandin, in Healthy Adults.Candidemia in a major regional tertiary referral hospital - epidemiology, practice patterns and outcomes.Preclinical Pharmacokinetics and Pharmacodynamic Target of SCY-078, a First-in-Class Orally Active Antifungal Glucan Synthesis Inhibitor, in Murine Models of Disseminated Candidiasis.Pharmacokinetics of the Novel Echinocandin CD101 in Multiple Animal Species.Performance of 1,3-β-D-glucan for diagnosing invasive fungal diseases in children.Invasive candidiasis: future directions in non-culture based diagnosis.How should we best treat patients with bloodstream infections?Pharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.Cost-effectiveness analysis of anidulafungin vs fluconazole for the treatment of invasive candidiasis (IC) in Turkey.Population Pharmacokinetic Model and Pharmacokinetic Target Attainment of Micafungin in Intensive Care Unit Patients Future therapies targeted towards eliminating Candida biofilms and associated infections.

P2860

Q26745677-BA3B100B-922F-464D-851D-2A2EA7585DA9 Q28077381-12C82F32-217C-4F55-BFEE-ACDA7F1B39F0 Q28109664-5DCF7CBD-5F69-4324-BD39-90CF0E9F72E6 Q28554057-C62D478A-7846-4817-AD1F-431EBA817487 Q28821330-B1965F4C-7524-4739-A7D5-C2EBFB0B8ECB Q30235457-6ED69001-EFEC-4C59-8195-11A4FEF82693 Q30274850-855C4991-ACA1-4173-BC98-2C07222B2B01 Q30376282-4BDCD91E-86FB-4373-9A41-A90CB68CAF66 Q30833475-793E848C-E867-4F7E-933A-7E9CEFC1C861 Q33574303-23B1AD35-D46C-41B1-B766-0F655AF8C2D3 Q33640559-16BC055A-B802-4B1A-9606-6E3E16DBA2EF Q33683476-A979FB6A-1F00-4E35-9E35-D370675297B3 Q33715460-3090ADDA-909F-4503-AFDF-50DE6FDB8103 Q33719829-9CDED21B-96F5-4032-A6E2-571BC2F02C89 Q33891810-B5706DBD-C8DA-417C-8226-BA85C9B6D479 Q33892834-4D36FDD7-6A00-41ED-8C7B-A803C1B3C19E Q36059265-6A1FB064-4DE7-48E0-9ED6-63BED42AB653 Q36285521-88B28765-EE14-430C-B2E1-C4FC73E17E2D Q36340864-6FC49362-FF3B-4D96-961C-5742738B86B1 Q36344076-F3EB3356-58E3-492C-91E5-6CC4D2518191 Q36396614-DD8361DA-CDF4-4219-90D1-B840078D0CB9 Q36933437-E1D49F96-E51B-4527-9E99-BFBB40BF61F3 Q37007553-9CC55441-8986-4497-8E80-0400E8DFC5DF Q37041199-CF912BD3-2446-4487-B3C3-506915119DFF Q37273918-A26FD19A-9CC3-4F2B-AA8F-56B6AA6F9CF9 Q37344546-7E0120F5-0967-462C-9103-17E66C6D4336 Q37394523-58E970CC-E647-4EAA-9502-EC398208593D Q37580801-8D073604-0BF5-4874-B763-7C8B61B3DA0F Q37594389-4FD4433F-6806-466B-83BE-1DBF78DFC387 Q37612980-C6061309-1CC2-4667-B4FC-8C832480F139 Q37694014-B4D693ED-15CB-4DF5-9302-78B1C6D9E9FE Q37720794-8EA3DD47-7268-48F7-BDB2-5D583B179B88 Q37720796-C9170906-7E5D-44E0-8D36-C17F3917AC16 Q38611989-1D323587-2F2E-4DBD-BD59-0F6DA9EA47DD Q38614492-095897B8-63F8-4CD5-A038-5AD4FB3754D0 Q38649423-567E349B-B319-4FF7-8B5E-86D0CDB52540 Q38681635-1AB9BFDB-D73A-4D67-8743-0C29099FBDD9 Q38682970-61079F41-FAE2-49E5-9F2B-01730A932FCC Q38763496-1DC56421-C944-46D6-8EB3-AD2BF2D622B6 Q38786061-661EFF71-DFBA-45BC-AC2A-0A5A4D80898D

P2860

Executive Summary: Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

http://www.wikidata.org/entity/Q28272494

description

2016 nî lūn-bûn

@nan

2016 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Executive Summary: Clinical Pr ...... us Diseases Society of America

@ast

Executive Summary: Clinical Pr ...... us Diseases Society of America

@en

Executive Summary: Clinical Pr ...... us Diseases Society of America

@nl

type

label

Executive Summary: Clinical Pr ...... us Diseases Society of America

@ast

Executive Summary: Clinical Pr ...... us Diseases Society of America

@en

Executive Summary: Clinical Pr ...... us Diseases Society of America

@nl

prefLabel

Executive Summary: Clinical Pr ...... us Diseases Society of America

@ast

Executive Summary: Clinical Pr ...... us Diseases Society of America

@en

Executive Summary: Clinical Pr ...... us Diseases Society of America

@nl

P1433

Q28272494-151F2E33-6555-4807-AC26-CD9147421E44

P1476

Q28272494-60418353-A7DB-42F5-B39E-DBA81139FCD3

P2093

Q28272494-03F8EF31-EDF0-49A4-9F95-D3263C44AC2C

Q28272494-0ABE80F7-F29C-4892-AB43-B97025019AAC

Q28272494-1A88D559-CAE9-42D4-B527-231651EB6E16

Q28272494-531A92C6-E679-46DA-8211-6C7DB096AEB7

Q28272494-6CE17A7C-3033-439B-AB3B-28509CCEDE9A

Q28272494-76EEC184-401D-4D7D-901D-5BCC5286B063

Q28272494-81071550-0540-4A7F-A62A-BD59DE539787

Q28272494-94BB27BF-973D-4290-A7DA-3E6C4FEE45C3

Q28272494-C0AB2D41-DF2E-482E-8D60-C69D95F98AD9

Q28272494-D23EEB67-279E-4368-A33A-BFCA51F4F6D5

P304

Q28272494-3C159672-F789-4ED3-8512-439FB053CF84

P31

Q28272494-5B3F7A75-F50B-41CE-9D17-2E84FE64AEA9

P3181

Q28272494-D3CC78DE-3014-497A-A235-1C0E3DBA5C23

P356

Q28272494-76F731E5-D120-4885-AAB7-70806346270F

P407

Q28272494-A7B5377B-D694-4258-899A-DE46C03CBFA8

P433

Q28272494-978144F7-45B3-4D8F-84C7-AF17BC2F95CD

P478

Q28272494-EC5E372A-D35B-4707-B856-DF75601C3B6D

P50

Q28272494-E964E273-CEF2-4099-AA89-7D59A971CE37

P577

Q28272494-008BDA8F-74F5-4652-A49A-8A88F89C5F50

P5875

Q28272494-0D3E4392-9621-49B7-A957-623FEC16B95F

P698

Q28272494-6C655EA2-045E-4746-93E9-3966C5B2952A

P3181

P356

P1433

Clinical Infectious Diseases

P1476

Executive Summary: Clinical Pr ...... us Diseases Society of America

@en

P2093

Annette C Reboli

http://www.w3.org/2001/XMLSchema#string

Carol A Kauffman

http://www.w3.org/2001/XMLSchema#string

Cornelius J Clancy

http://www.w3.org/2001/XMLSchema#string

Jack D Sobel

http://www.w3.org/2001/XMLSchema#string

Jose A Vazquez

http://www.w3.org/2001/XMLSchema#string

Kieren A Marr

http://www.w3.org/2001/XMLSchema#string

Luis Ostrosky-Zeichner

http://www.w3.org/2001/XMLSchema#string

Mindy G Schuster

http://www.w3.org/2001/XMLSchema#string

Peter G Pappas

http://www.w3.org/2001/XMLSchema#string

Theoklis E Zaoutis

http://www.w3.org/2001/XMLSchema#string

P304

409-417

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2455302

http://www.w3.org/2001/XMLSchema#string

P356

10.1093/CID/CIV1194

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

62

http://www.w3.org/2001/XMLSchema#string

P50

P577

2016-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291955025

http://www.w3.org/2001/XMLSchema#string

P698

26810419

http://www.w3.org/2001/XMLSchema#string